U.S. markets close in 5 hours 37 minutes
  • S&P 500

    4,034.49
    +16.72 (+0.42%)
     
  • Dow 30

    33,761.64
    +44.55 (+0.13%)
     
  • Nasdaq

    11,463.09
    +69.28 (+0.61%)
     
  • Russell 2000

    1,899.45
    +13.73 (+0.73%)
     
  • Crude Oil

    78.35
    +0.45 (+0.58%)
     
  • Gold

    1,937.30
    -1.90 (-0.10%)
     
  • Silver

    23.64
    -0.09 (-0.39%)
     
  • EUR/USD

    1.0848
    -0.0008 (-0.08%)
     
  • 10-Yr Bond

    3.5290
    -0.0220 (-0.62%)
     
  • GBP/USD

    1.2297
    -0.0057 (-0.46%)
     
  • USD/JPY

    130.0530
    -0.3050 (-0.23%)
     
  • BTC-USD

    23,147.32
    -89.41 (-0.38%)
     
  • CMC Crypto 200

    524.76
    +5.97 (+1.15%)
     
  • FTSE 100

    7,761.83
    -23.04 (-0.30%)
     
  • Nikkei 225

    27,327.11
    -106.29 (-0.39%)
     

Alzheimer’s Breakthrough Is Boost for Biogen, Eli Lilly Despite Side-Effect Concerns

Alzheimer’s Breakthrough Is Boost for Biogen, Eli Lilly Despite Side-Effect Concerns

Shares in pharmaceutical companies rose after the publication of a paper detailing the apparent benefits of the lecanemab drug.